Report ID |
168941 |
Drug Identification Number |
02238830 |
Brand name |
CLAVULIN 400 |
Common or Proper name |
amoxicillin / clavulanate potassium for oral suspension |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
MARKETED |
Active Ingredient(s) |
AMOXICILLIN
CLAVULANIC ACID |
Strength(s) |
400MG
57MG |
Dosage form(s) |
POWDER FOR SUSPENSION |
Route of administration |
ORAL
ORAL |
Packaging size |
70ML |
ATC code |
J01CR |
ATC description |
BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage |
Demand increase for the drug. |
Anticipated start date |
|
Actual start date |
2022-09-05 |
Estimated end date |
2023-03-31 |
Actual end date |
2023-03-15 |
Shortage status |
Resolved |
Updated date |
2024-02-14 |
Company comments |
Inventory on allocation to support demand. For emergency supply, contact GSK Customer Service 1-800-387-7374. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
1-800-387-7374 |